Erythema chronicum migrans
Revisione paritaria di Dr Doug McKechnie, MRCGPUltimo aggiornamento di Dr Colin Tidy, MRCGPUltimo aggiornamento 12 giu 2023
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Versione audio
- Add to preferred sources on Google
Professionisti Medici
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our articoli sulla salute more useful.
In questo articolo:
Continua a leggere sotto
Cos'è l'eritema cronico migrante?
Erythema chronicum migrans is a characteristic clinical feature of Lyme disease (Lyme borreliosis). It is a distinctive rash, which occurs in the majority of people infected with Borrelia burgdorferi. This infection is transmitted to humans by the bite of a tick from the genus Ixodes.
How common is erythema chronicum migrans? (Epidemiology)1
Torna ai contenutiLyme disease is not common in the UK, with an estimated 2,000 to 3,000 new cases each year in England and Wales.
Nel Regno Unito, le aree in cui si contrae l'infezione includono Exmoor, la New Forest, le South Downs, alcune parti di Wiltshire e Berkshire, Surrey, West Sussex, la foresta di Thetford, il Lake District, le brughiere del North Yorkshire e le Highlands scozzesi.
Infection may also be acquired abroad and mostly by holidaymakers. The majority are acquired in the USA, France, Germany, Scandinavia and other northern, eastern and central European countries. The infection can also be found in temperate forested areas of Asia, including Russia, China and Japan.
In Europe erythema chronicum migrans occurs as a presenting feature in up to 90% of those infected.2 Presentation does appear to depend upon the Borrelia species involved; therefore, in other parts of the world the rash may be a less common presenting sign.
Continua a leggere sotto
Sintomi dell'eritema migrante cronico (presentazione)3
Torna ai contenutiThe characteristic manifestation of early Lyme disease (stage 1) is erythema chronicum migrans: a circular rash at the site of the infectious tick attachment, which radiates from the bite. It can appear within 3-36 days, but typically in 7-10.
It starts as a red macule or papule at the site of the tick bite after a (typically 7- to 10-day) delay.
The rash is round or oval, and pink, red or purple. There is often central sparing giving a target-like appearance, and the diameter is usually larger than 5 cm. The nature of the rash and the likelihood of its presence are partly dependent on the species involved and therefore differ between continents.
Eritema migrante 'a bersaglio' dell'infezione da Lyme

© CDC/James Gathany, di pubblico dominio, tramite Wikimedia Commons
Untreated, this can last for some weeks, but eventually resolves.
Common areas include the popliteal fossa, groin, the axilla, the thorax and the trunk. The hairline and scalp are especially common in children.
It may be associated with other symptoms of infection, including fatigue, myalgia, arthralgia, headache, fever, stiff neck, and regional lymphadenopathy.
It may also be associated with later developments such as carditis, neurological disease, arthritis, and acrodermatitis chronica atrophicans (a swollen, bluish-red skin lesion on a distal extremity).
The National Institute for Health and Care Excellence (NICE) recommends diagnosing Lyme disease in people with erythema migrans that:4
Increases in size and may sometimes have a central clearing.
Is not usually itchy, hot or painful.
Usually becomes visible from 1 to 4 weeks (but can appear from 3 days to 3 months) after a tick bite and lasts for several weeks.
Is usually at the site of a tick bite.
In the absence of erythema migrans, the diagnosis of Lyme disease can be very difficult with non-specific clinical signs and symptoms that may or may not be supported by laboratory evidence.5
Diagnosi differenziale6
Torna ai contenutiLocal tick bite reactions.
Continua a leggere sotto
Indagini1 3
Torna ai contenutiFor anyone with erythema migrans who have no evidence of focal symptoms of Lyme disease (eg neurological, cardiac, or joint involvement), investigations are not required and start treatment with oral antibiotics (see below).
Management of erythema chronicum migrans4 7
Torna ai contenutiAlthough the rash will resolve spontaneously over weeks or months, antibiotics help prevent progression to disseminated Lyme disease.
For the treatment of Lyme disease without focal symptoms (eg, neurological, carditis) but with erythema migrans and/or non-focal symptoms, NICE recommends:
First choice: oral doxycycline: 100 mg twice per day or 200 mg once per day for 21 days.
First alternative: oral amoxicillin: 1 g 3 times per day for 21 days.
Second alternative: oral azithromycin: 500 mg daily for 17 days (azithromycin should not be used to treat people with cardiac abnormalities associated with Lyme disease because of its effect on QT interval).
Prevention of erythema chronicum migrans
Torna ai contenutiAvoid exposure to tick bites.
Remove ticks as soon as possible. Ticks take some time to transmit infection, so this may be prevented if removed quickly.
Antibiotic prophylaxis can be offered in endemic areas under certain circumstances if the tick bite can be positively identified.
Ulteriori letture e riferimenti
- Mygland A, Ljostad U, Fingerle V, et al; EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16, e1-4. doi: 10.1111/j.1468-1331.2009.02862.x. Epub 2009 Nov 23.
- Erythema chronicum migrans; DermIS (Sistema Informativo di Dermatologia)
- Prevention and control of tick-borne disease in Europe - Information to healthcare professionals; Centro europeo per la prevenzione e il controllo delle malattie
- Coburn J, Garcia B, Hu LT, et al; Patogenesi della malattia di Lyme. Problemi attuali nella biologia molecolare. 2021;42:473-518. doi: 10.21775/cimb.042.473. Epub 23 dicembre 2020.
- Lyme disease (and erythema migrans); Primary Care Dermatology Society (PCDS). Last updated May 2022.
- malattia di Lyme; DermNet.
- Malattia di Lyme: guida, dati e analisi; Public Health England - ora UK Health Security Agency (ultimo aggiornamento 2022)
- The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association; J Infect. 2011 May;62(5):329-38. doi: 10.1016/j.jinf.2011.03.006. Epub 2011 Mar 21.
- malattia di Lyme; NICE CKS, novembre 2022 (accesso solo Regno Unito)
- malattia di Lyme; Linee guida NICE (aprile 2018 - ultimo aggiornamento ottobre 2018)
- Bobe JR, Jutras BL, Horn EJ, et al; Progressi recenti nella malattia di Lyme e sfide ancora da affrontare. Front Med (Lausanne). 18 ago 2021;8:666554. doi: 10.3389/fmed.2021.666554. eCollection 2021.
- Shapiro ED; Pratica clinica. Malattia di Lyme. N Engl J Med. 2014 1 maggio;370(18):1724-31. doi: 10.1056/NEJMcp1314325.
- Formulario Nazionale Britannico (BNF); Servizi di Evidenza NICE (accesso solo nel Regno Unito)
Continua a leggere sotto
About the author

Dr Colin Tidy, MRCGP
Medico di base, Autore medico
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy is an NHS Doctor, based in Oxfordshire.
About the reviewerView full bio

Dr Doug McKechnie, MRCGP
Medical Writer
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Dr Doug McKechnie is an NHS GP working in London. He works full-time clinically and is also the Deputy Lead for the Clinical and Professional Practice module at University College London Medical School.
Storia dell'articolo
Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
Prossima revisione prevista: 12 maggio 2028
12 giu 2023 | Ultima versione

Chiedi, condividi, connettiti.
Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Non ti senti bene?
Valuta i tuoi sintomi online gratuitamente